Delhi HC Reserves Verdict in Semaglutide Patent Case
Delhi High Court's division bench reserves verdict on Novo Nordisk's appeal against order allowing Dr Reddy's and Sun Pharma to export generic semaglutide. Decision will impact India's growing diabetes drug market.